Get started
Author

Oumarou Nabi

Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)
2023 · Oumarou Nabi, Nathanaël Lapidus, et al. · Hepatology · 118
PDF
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study
2020 · Oumarou Nabi, Karine Lacombe, et al. · Gastroenterology · 78
Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community‐based cohort
2022 · Coralie Amadou, Oumarou Nabi, et al. · Hepatology · 39
Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study)
2021 · Oumarou Nabi, Jerome Boursier, et al. · Digestive Diseases and Sciences · 25
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population‐based follow‐up study ( NASHCO )
2022 · Oumarou Nabi, Jerome Boursier, et al. · Liver International · 21
PDF
The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study ( NASH‐CO study)
2023 · Oumarou Nabi, Nathanaël Lapidus, et al. · Liver International · 19
PDF
Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort
2026 · Oumarou Nabi, Jonas Spaak, et al. · Journal of Internal Medicine · 7
PDF
THU-340-Epidemiology of NAFLD and advanced fibrosis in the French general population: A population-based cohort study in 118, 664 subjects (NASH-CO study)
2019 · Lawrence Serfaty, Oumarou Nabi, et al. · Journal of Hepatology · 6
Racialized Economic Segregation and Disparities in Non-Small Cell Lung Cancer Care and Outcomes
2024 · Pratibha Shrestha, Min Lian, et al. · CHEST Pulmonary · 4
PDF
Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
2024 · Bayu B. Bekele, Min Lian, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
PDF
The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast
2024 · Oumarou Nabi, Ying Liu, et al. · Cancer Epidemiology Biomarkers & Prevention · 1
PDF
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD
2024 · Oumarou Nabi, Nathanaël Lapidus, et al. · Hepatology · 1
Reply
2022 · Coralie Amadou, Oumarou Nabi, et al. · Hepatology · 1
Data from The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast
2024 · Oumarou Nabi, Ying Liu, et al.
Table S1 from The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast
2024 · Oumarou Nabi, Ying Liu, et al.
Data from Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
2024 · Bayu B. Bekele, Min Lian, et al.
Data from Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
2024 · Bayu B. Bekele, Min Lian, et al.
Table S1 from Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
2024 · Bayu B. Bekele, Min Lian, et al.
Table S1 from Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
2024 · Bayu B. Bekele, Min Lian, et al.
Spatio-Temporal Trend and Geographic Disparity of Infertility Prevalence in Burkina Faso, 2011 to 2020
2024 · Oumarou Nabi, René Tokira Poubouré Yabré, et al. · Open Journal of Obstetrics and Gynecology
PDF
Baclofen is effective on abstinence and improvement of Child-Pugh score in patients with cirrhosis: results of a meta-analysis
2023 · Gildas Fantognon, Jean-François Cadranel, et al. · Journal of Hepatology
La stéatose hépatique non alcoolique en France, épidémiologie et pronostic : analyse des données de la cohorte Constances et du Système National des Données de Santé (SNDS)
2022 · Oumarou Nabi
Hepatitis C and NAFLD as Main Causes of Liver-Related Morbidity and Mortality in the French General Population: A Nationwide Study (NASH-CO Study)
2022 · Oumarou Nabi, Nathanaël Lapidus, et al. · SSRN Electronic Journal
Lean NAFLD from the General French Population have more Severe Liver Disease and Poorer Clinical Outcomes (NASH-CO Study)
2021 · Nabi, Oumarou, Lapidus, Nathanaël, et al. · HAL
Additive Effects of Diabetes and NAFLD on Liver Disease Severity and Clinical Outcomes in the General Population (NASH-CO Study)
2021 · Nabi, Oumarou, Lapidus, Nathanaël, et al. · HAL
Works count: 28
Citation count: 323
H-index: 7
I10-index: 6
Year
Topic
Type